<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic and sodium phosphate, monobasic, monohydrate tablet </strong><br>Cardinal Health<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>PHOSPHA 250™ NEUTRAL <br> Supplies 250 mg of phosphorus per tablet</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_2c8ff242-eb29-4f98-bfd4-3125aabbebe4"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg monobasic potassium phosphate, and 130 mg monobasic sodium phosphate monohydrate. Each tablet yields approximately 250 mg of phosphorus, 298 mg of sodium (13.0 mEq) and 45 mg of potassium (1 .1 mEq).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_5054bc74-81ed-4fbe-a6a1-c17f50cfed8c"></a><a name="section-2"></a><p></p>
<h1>OTHER INGREDIENTS</h1>
<p class="First">Purified Water, Lactose Monohydrate, Sodium Starch Glycolate, Polyvinyl Pyrrolidone, Magnesium Stearate, Hydroxypropyl methylcellulose, Polyethylene Glycol 400, Titanium dioxide.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_64749b5b-4746-4279-bbf6-44335c62ef44"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Phosphorus has a number of important functions in the biochemistry of the body. The bulk of the body's phosphorus is located in the bones, where it plays a key role in osteoblastic and osteoclastic activities. Enzymatically catalyzed phosphate-transfer reactions are numerous and vital in the metabolism of carbohydrate, lipid and protein, and a proper concentration of the anion is of primary importance in assuring an orderly biochemical sequence. ln addition, phosphorus plays an important role in modifying steady-state tissue concentrations of calcium. Phosphate ions are important buffers of the intracellular fluid, and also play a primary role in the renal excretion of the hydrogen ion.</p>
<p>Oral administration of <span class="product-label-link" type="condition" conceptid="4106483" conceptname="P">inorganic phosphates</span> increases serum phosphate levels. Phosphates lower urinary calcium levels in idiopathic <span class="product-label-link" type="condition" conceptid="4215809" conceptname="Hypercalciuria">hypercalciuria</span>.</p>
<p>In general, in adults, about two thirds of the ingested phosphate in absorbed from the bowel, most of which is rapidly excreted into the urine.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_5d38166d-cb52-46de-8c1f-f529c6185be3"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">PHOSPHA 250<span class="Sup">TM</span> NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_b9265fa4-22e2-4a57-a0fd-00ad4ee183ff"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">This product is contraindicated in patients with infected phosphate stones, in patients with severely <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span> (less than 30% of normal) and in the presence of <span class="product-label-link" type="condition" conceptid="4065502" conceptname="Hyperphosphatemia">hyperphosphatemia</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_48b519c2-a1bf-4cb8-92ab-f619db7e1cf9"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
</div>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_d617e06e-3bd4-4853-90bd-868988e2cba5"></a><a name="section-7"></a><p></p>
<h1>General:</h1>
<p class="First">This product contains potassium and sodium and should be used with caution if regulation of these elements is desired. Occasionally, some individuals may experience a mild laxative effect during the first few days of phosphate therapy. If laxation persists to an unpleasant degree reduce the daily dose until this effect subsides or, if necessary, discontinue the use of the product. </p>
<p>Caution should be exercised when prescribing this product in the following conditions: Cardiac disease (particularly in digitalized patients); severe <span class="product-label-link" type="condition" conceptid="193984" conceptname="Adrenal hypofunction">adrenal insufficiency</span> (Addison's disease); acute <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>; severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>; renal function impairment or chronic <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>; extensive tissue breakdown (such as severe <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span>); <span class="product-label-link" type="condition" conceptid="4212349" conceptname="Congenital myotonia, autosomal dominant form">myotonia congenita</span>; <span class="product-label-link" type="condition" conceptid="316139" conceptname="Heart failure">cardiac failure</span>; cirrhosis of the liver or severe <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic disease</span>; peripheral or <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>; <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>; <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>; <span class="product-label-link" type="condition" conceptid="439393" conceptname="Pre-eclampsia">toxemia of pregnancy</span>; <span class="product-label-link" type="condition" conceptid="140362" conceptname="Hypoparathyroidism">hypoparathyroidism</span>; and <span class="product-label-link" type="condition" conceptid="199074" conceptname="Acute pancreatitis">acute pancreatitis</span>. <span class="product-label-link" type="condition" conceptid="4189941" conceptname="Rickets">Rickets</span> may benefit from phosphate therapy, but caution should be exercised. High serum phosphate levels may increase the incidence of extraskeletal calcification.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_89850b40-940e-4a0d-ae15-1e881f1e4f2a"></a><a name="section-8"></a><p></p>
<h1>Information for Patients:</h1>
<p class="First">Patients with <span class="product-label-link" type="condition" conceptid="201620" conceptname="Kidney stone">kidney stones</span> may pass old stones when phosphate therapy is started and should be warned of this possibility. Patients should be advised to avoid the use of antacids containing aluminum, magnesium, or calcium which may prevent the absorption of phosphate.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="i4i_lab_tests_id_93ba0f83-9294-4b39-99b6-2c40b7497c71"></a><a name="section-9"></a><p></p>
<h1>Laboratory Tests:</h1>
<p class="First">Careful monitoring of renal function and serum calcium, phosphorus, potassium, and sodium may be required at periodic intervals during phosphate therapy. Other tests may be warranted in some patients, depending on conditions.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_interactions_id_c35b8e0b-778f-4678-8938-08142c7a9a32"></a><a name="section-10"></a><p></p>
<h1>Drug Interactions:</h1>
<p class="First">The use of antacids containing magnesium, aluminum, or calcium in conjunction with phosphate preparations may bind the phosphate and prevent its absorption. Concurrent use of antihypertensives, especially diazoxide, guanethidine, hydralazine, methyldopa, or rauwolfia alkaloid; or corticosteroids, especially mineralocorticoids or corticotropin with sodium phosphate may result in <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>. Calcium-containing preparations and/or Vitamin D may antagonize the effects of phosphates in the treatment of <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span>. Potassium-containing medication or potassium-sparing diuretics may cause <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>. Patients should have serum potassium level determinations at periodic intervals.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_cbd31aa2-1d69-4372-aebc-8228bbb14da2"></a><a name="section-11"></a><p></p>
<h1>Carcinogenesis, Mutagenesis, Impairment of Fertility:</h1>
<p class="First">No long term or reproduction studies in animals or humans have been performed with PHOSPHA 250<span class="Sup">TM</span> NEUTRAL to evaluate its carcinogenic, mutagenic, or impairment of fertility potential.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_52245e35-466d-4af7-861c-cf7c69497bed"></a><a name="section-12"></a><p></p>
<h1>Pregnancy:</h1>
</div>
<div class="Section" data-sectionCode="34077-8">
<a name="i4i_teratogenic_id_073623e9-731d-4ed0-bf13-0d9d9b2c80bb"></a><a name="section-13"></a><p></p>
<h1>Teratogenic Effects. Pregnancy Class C.</h1>
<p class="First"> Animal reproduction studies have not been conducted with PHOSPHA 250<span class="Sup">TM</span> NEUTRAL. It is also not known whether this product can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity.</p>
<p>This product should be given to a pregnant woman only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_cb415419-86e7-4625-82fc-409b2d265062"></a><a name="section-14"></a><p></p>
<h1>Nursing Mothers:</h1>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_39b0823b-bbb2-45c1-9f16-bb67a4ec6e49"></a><a name="section-15"></a><p></p>
<h1>Pediatric Use:</h1>
<p class="First"><span class="Bold">See <a href="#i4i_dosage_admin_id_13e80dd7-0162-4905-b2e4-39a2819a35fd">DOSAGE AND ADMINISTRATION</a></span>. </p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_eb55cbf3-f10e-4622-82d7-7bce32678324"></a><a name="section-16"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4183041" conceptname="Abdominal discomfort">Gastrointestinal upset</span> (<span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">stomach pain</span>, and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>) may occur with phosphate therapy. Also, bone and <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">joint pain</span> (possible phosphate-induced <span class="product-label-link" type="condition" conceptid="432594" conceptname="Osteomalacia">osteomalacia</span>) could occur. The following adverse effects may be observed (primarily from sodium or potassium): <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>; <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>; <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>; <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span>; <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span> or heaviness of legs; unusual <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span> or <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>; <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">muscle cramps</span>; <span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">numbness</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span>, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> or <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span> of hands or feet; <span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">numbness</span> or <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span> around lips; fast or irregular heartbeat; <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">shortness of breath</span> or troubled breathing; <span class="product-label-link" type="condition" conceptid="133299" conceptname="Swelling of limb">swelling of feet</span> or lower legs; unusual <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span>; low urine output; unusual <span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">thirst</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_13e80dd7-0162-4905-b2e4-39a2819a35fd"></a><a name="section-17"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">PHOSPHA 250<span class="Sup">TM</span> NEUTRAL tablets should be taken with a full glass of water, with meals and at bedtime.</p>
<p><span class="Bold">Adults:</span> One or two tablets, four times daily;</p>
<p><span class="Bold">Pediatric patients over 4 years of age:</span> One tablet four times daily.</p>
<p><span class="Bold">Pediatric Patients under 4 years of age:</span> Use only as directed by physician.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_8ec55236-7d4b-47af-b460-30cc4931ec8e"></a><a name="section-18"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">White, film-coated, capsule-shaped tablet, debossed with RIS 1 04 on each tablet.</p>
<p>NDC #64980-1 04-01 <br> Bottles of 1 00 tablets</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="i4i_storage_id_ac29e075-18bc-4b6c-a8bd-3fe90c13c4f1"></a><a name="section-19"></a><p></p>
<h1>STORAGE</h1>
<p class="First">Keep tightly closed. Store at controlled room temperature 20°-25°C (68°-77°F}. Dispense in tight, light-resistant containers with child resistant closures. </p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_e1c80170-7be9-4959-8f38-c4b0567b7bf7"></a><a name="section-20"></a><p></p>
<h1>IDENTITY: Phospha 250<span class="Sup">TM</span> Neutral</h1>
<p class="First">is an orally administered medical food for use only under medical supervision for the dietary management of <span class="product-label-link" type="condition" conceptid="4177973" conceptname="Hypophosphatemia">hypophosphatemia</span>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_adf61cb5-c0eb-4067-9bd9-7ebe0e3b95ff"></a><a name="section-21"></a><p></p>
<p class="First">Manufactured for: <br><span class="Bold">Rising Pharmaceuticals, Inc.</span><br> 3 Pearl Court<br> Allendale, NJ 07 401</p>
<p>Manufactured by: <br><span class="Bold">Mirror Pharmaceuticals LLC.</span><br> Fairfield, NJ 07004</p>
<p>PHOSPHA 250<span class="Sup">TM </span> Neutral tablets are available from Cardinal Health in unit dose packages of  100.</p>
<p>NDC 55154-7676-4, Unit dose package of 100.</p>
<p>Rx only</p>
<p>5503 Rev 10/13</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_25e78818-831c-4d0d-80c8-380f8a0cd1f2"></a><a name="section-22"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First"><span class="Bold">Phospha 250<span class="Sup">TM</span> Neutral</span></p>
<p><span class="Bold">phosphourus supplement </span> Tablet</p>
<p>250 mg</p>
<div class="Figure">
<a name="id1564374880"></a><img alt="pouch label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c59ebbf8-a85f-4531-8635-7d481db14a5a&amp;name=image-01.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_c7d52abb-1361-403a-b75e-8b44373fffb6"></a><a name="section-23"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First"><span class="Bold">Phospha 250<span class="Sup">TM</span> Neutral</span></p>
<p><span class="Bold">phosphourus supplement </span> Tablet</p>
<p>250 mg</p>
<p>100 Tablets</p>
<div class="Figure">
<a name="id391"></a><img alt="Carton Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c59ebbf8-a85f-4531-8635-7d481db14a5a&amp;name=image-02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_b58eea6a-454d-47c6-9991-4ed53ffd0b6d"></a><a name="section-24"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First"><span class="Bold">Phospha 250<span class="Sup">TM</span> Neutral</span></p>
<p><span class="Bold">phosphourus supplement </span> Tablets</p>
<p>250 mg</p>
<p>10 Tablets</p>
<div class="Figure">
<a name="id402"></a><img alt="Bag label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c59ebbf8-a85f-4531-8635-7d481db14a5a&amp;name=image-03.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE 		
					</strong><br><span class="contentTableReg">dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:55154-7676(NDC:64980-104)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM PHOSPHATE, DIBASIC, ANHYDROUS</strong> (PHOSPHATE ION) </td>
<td class="formItem">SODIUM PHOSPHATE, DIBASIC, ANHYDROUS</td>
<td class="formItem">852 mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM PHOSPHATE, MONOBASIC</strong> (PHOSPHATE ION) </td>
<td class="formItem">POTASSIUM PHOSPHATE, MONOBASIC</td>
<td class="formItem">155 mg</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE</strong> (PHOSPHATE ION) </td>
<td class="formItem">SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE</td>
<td class="formItem">130 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>LACTOSE MONOHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONE K30</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYPROMELLOSE 2910 (15000 MPA.S)</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 400</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE</td>
<td class="formLabel">Size</td>
<td class="formItem">9mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">RIS;104</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:55154-7676-4</td>
<td class="formItem">100  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:55154-7676-6</td>
<td class="formItem">1  in 1 POUCH</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:55154-7676-0</td>
<td class="formItem">10  in 1 BAG</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">1  in 1 POUCH</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">06/28/2012</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Cardinal Health
							(188557102)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Mirror Pharmaceuticals, LLC (964680206)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Cardinal Health</td>
<td class="formItem"></td>
<td class="formItem">188557102</td>
<td class="formItem">REPACK(55154-7676)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 7/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>9cde8725-a403-4ce1-85e3-f5634636b5fc</div>
<div>Set id: c59ebbf8-a85f-4531-8635-7d481db14a5a</div>
<div>Version: 4</div>
<div>Effective Time: 20140717</div>
</div>
</div> <div class="DistributorName">Cardinal Health</div></p>
</body></html>
